Education Library

Katherine Kunkel, MD, discusses data-driven decision making and best practices in cardiogenic shock at TCT 2022. 

Junya Ako, MD, presents outcomes in AMI cardiogenic shock from Japan's J-PVAD study at TCT 2022.

William O’Neill, MD, discusses the current state of mechanical circulatory support for AMI cardiogenic shock.
 

Amir Kaki, MD, describes best practices and practical considerations for optimizing care of patients with AMI cardiogenic shock prior to leaving the cath lab.

Arman Kilic, MD, discusses his experiences with collaboration between interventional cardiology and cardiac surgery, particularly regarding Impella 5.5® with SmartAssist® and ECpella.

Mario Iannaccone, MD, discusses his meta-analysis data supporting pre-PCI placement of Impella® for AMI cardiogenic shock.

Chuck Simonton, MD, discusses the limitations of published papers that use administrative or payer databases as data sources and provides an AMI cardiogenic shock example.

Ole Helgestad, PhD, discusses an automated variable selection method for predicting 30-day mortality in patients with AMICS receiving acute PCI. 

Benedikt Schrage, MD, discusses his paper examining how enrollment criteria in RCTs apply to the real-world cardiogenic shock patient population.

Babar Basir, DO, presents the National Cardiogenic Shock Initiative (NCSI) protocol for managing acute myocardial infarction cardiogenic shock (AMICS) at the 2021 HFSA scientific meeting.

Timothy Smith, MD, discusses the importance of the cardiovascular ICU and device management for patients with cardiogenic shock supported with the Impella® heart pump.

Rajan Patel, MD, discusses clinical data supporting Impella® use in Protected PCI and cardiogenic shock at the CRT 2021 virtual annual symposium. 

This FAQ discusses how IABP works and the role of IABP in Protected PCI and cardiogenic shock.

Patrick Horn, MD, discusses his recently published paper investigating the impact of left ventricular unloading on pulmonary congestion and pneumonia in patients with cardiogenic shock.

The final results of the physician-led NCSI Study demonstrate a 71% survival to discharge with greater than 90% native heart recovery when best practices are used.